Aldosterone as a Determinant of Cardiovascular and Renal Dysfunction
Open Access
- 1 August 2001
- journal article
- review article
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 94 (8) , 378-383
- https://doi.org/10.1177/014107680109400803
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Local Angiotensin II and Transforming Growth Factor-β1 in Renal Fibrosis of RatsHypertension, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Aldosteroneʼs effects and mechanism of actionCurrent Opinion in Endocrinology, Diabetes and Obesity, 1997
- Rapid Effects of Aldosterone on Sodium Transport in Vascular Smooth Muscle CellsHypertension, 1995
- Mineralocorticoids, hypertension, and cardiac fibrosis.Journal of Clinical Investigation, 1994
- Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertensionThe American Journal of Cardiology, 1993
- Remodeling and reparation of the cardiovascular systemJournal of the American College of Cardiology, 1992
- Antialdosterones: Incidence and prevention of sexual side effectsJournal of Steroid Biochemistry, 1989
- Efficacy and tolerance of spironolactone in essential hypertensionThe American Journal of Cardiology, 1987
- Effect of aldosterone on vascular angiotensin II receptors in the ratCanadian Journal of Physiology and Pharmacology, 1985